Sort
82,697 grants matching “vaccine development”
Evaluation of Antibody Responses Elicited by Zika Vaccination in Flavivirus-naïve and -experienced Individuals
$864,207Shelly J Krebs · Henry M. Jackson Fdn For The Adv Mil/Med · R01 · FY2021 · AI
Characterization of a low mutation rate E. coli in extended fermentation
$864,106Frederick R Blattner · Scarab Genomics, Llc · R44 · FY2017 · GM
Influenza pathogenesis in pregnancy
$864,027Kristina M Adams Waldorf · University Of Washington · R01 · FY2021 · AI
Signal Transduction Events and the Regulation of Cell Growth
$864,019Jane B Trepel · Division Of Clinical Sciences - Nci · ZIC · FY2014 · CA
DCP - COPTRG - SELECT/PCPT
$863,914Leonard Freedman · Leidos Biomedical Research, Inc. · N01 · FY2021 · CA
HLA Chip Product for FDA 510K Approval
$863,882Krishna Jayaraman · Genomics Usa, Inc. · R44 · FY2011 · AI
COVID-19 vaccine development
$863,806George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Clinical trials employing cancer vaccine combination therapies
$863,733James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Production and purification of biological compounds
$863,716Joseph Shiloach · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIC · FY2018 · DK
How antigen exposure shapes the subsequent NK cell response to HIV
$863,699Silke Paust · Scripps Research Institute, The · R01 · FY2022 · AI
Mesothelin-targeted immunotoxins in Pancreatic Cancer
$863,617Christine Alewine · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
The generation and protective function of lung tissue resident memory T cells following SARS-CoV-2 infection or vaccination
$863,551John Ross Teijaro · Scripps Research Institute, The · R01 · FY2025 · AI
Host Immune Responses to Antigens of Malaria Parasites
$863,547Carole Long · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
The Environmental Determinants of Diabetes in Youth: Washington Clinical Center
$863,379William A. Hagopian · Pacific Northwest Research Institute · U01 · FY2012 · DK
A Tetravalent Dengue Vaccine Based on Alphavirus Replicons
$863,336Laura J White · Univ Of North Carolina Chapel Hill · U01 · FY2008 · AI
Proteomics Core
$863,234S Munir Alam · Duke University · U19 · FY2011 · AI
Antibody Based Therapeuticcs for Chikungunya Virus
$863,223Michael S. Diamond · Washington University · R01 · FY2011 · AI
Targeted genetic engineering of B cells to induce protective antibody responses to viral pathogens
$863,175Jennifer Eileen Adair · Fred Hutchinson Cancer Center · R01 · FY2022 · AI
IMPACT OF FARMING ENVIRONMENT ON IMMUNE MATURATION AND RESPIRATORY HEALTH
$863,116James E. Gern · University Of Wisconsin-Madison · U19 · FY2015 · AI
Plasmodium vivax recombinant CS protein vaccine for malaria
$863,049B. Kim Lee Sim · Protein Potential, Llc · R44 · FY2012 · AI
Cross talk between keratinocytes and skin-resident T-cells influences HSV recurrence
$862,878Jia Zhu · Fred Hutchinson Cancer Center · R01 · FY2025 · AI
Novel immunotherapeutics against multidrug-resistant Neisseria gonorrhoea
$862,755Sanjay Ram · Univ Of Massachusetts Med Sch Worcester · R01 · FY2021 · AI
Novel Adjuvant Discovery in Vaccine Therapy
$862,703Jason S Lewis · Sloan-Kettering Inst Can Research · R01 · FY2010 · AI
Development of vaccination strategies to elicit broadly protective immunity against influenza
$862,508Jeffrey Victor Ravetch · Rockefeller University · R01 · FY2024 · AI
A new humanized mouse model to study HBV gene editing
$862,440Keith R Jerome · Fred Hutchinson Cancer Center · R01 · FY2024 · AI